Archives for March 26, 2015

← 2015

CRO pricing power remains ‘elusive,’ analyst says

By Zachary Brennan

As biotech and mid-sized pharma companies continue to drive growth for CROs (contract research organizations), the expected ramping up of prices due to increased competition has yet to fully materialize, experts say.